Reformulated Light-Activated Cream for Actinic Keratosis on Face or Scalp
Part of Cancer, Skin clinical trials.
This trial tests a reformulated light-activated cream (Levulan Kerastick) for treating actinic keratosis (precancerous skin spots) on the face or bald scalp. It is a phase 3 study to see if the new version works better with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You should be between 18 and 85 years old.
- You must have 4 to 8 mild to moderate actinic keratosis (AK) spots (rough, scaly patches) on your face or bald scalp, not both.
- You must be in good general health and willing to avoid tanning beds or sunbathing.
- You cannot use any other AK treatments (like creams, freezing, or light therapy) on the area for at least 2 months before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new gel and light treatment for actinic keratosis (rough, sun-damaged spots) on the arm. It aims to see if it can safely remove these spots and prevent new ones.
This study tests an investigational drug called HW211026 on actinic keratosis — rough, sun-damaged patches on the face. The goal is to see if this treatment can safely clear them up.
This study tests a treatment applied to the forearms to help the skin heal and reduce the chance of pre-cancerous spots coming back in veterans who have had many sun-damaged areas.
This study compares two ways to treat sun-damaged spots called actinic keratoses: freezing them (cryotherapy) or applying a chemotherapy cream (5-fluorouracil). The goal is to see which works better and is safer for people with many spots on their head, neck, arms, or legs.
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
This study tests whether tirbanibulin (Klisyri) cream works well on specific types of actinic keratosis on the scalp or face that have a downward growth pattern. It helps doctors understand if this treatment is right for those skin spots.
Hear when a new Actinic Keratosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.